Adverse Event Clinical Research R4 Backport, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-backport-ig/ and changes regularly. See the Directory of published versions
<AdverseEvent xmlns="http://hl7.org/fhir">
<id value="adverse-event-compass-ex1b"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/AdverseEvent-clinical-research"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: AdverseEvent</b><a name="adverse-event-compass-ex1b"> </a><a name="hcadverse-event-compass-ex1b"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource AdverseEvent "adverse-event-compass-ex1b" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-AdverseEvent-clinical-research.html">Adverse Event Clinical Research</a></p></div><p><b>Resulting Effect</b>: <span>: Reference to Observation of Alanine aminotransferase (ALT) decreased to 60</span></p><blockquote><p><b>Supporting information relevant to the event</b></p><blockquote><p><b>url</b></p><code>item</code></blockquote><p><b>value</b>: <span>: Supporting info would have context such as an Reference to Observation of Alanine aminotransferase (ALT) decreased to 60</span></p></blockquote><p><b>Adverse Event Grade</b>: Grade 1 Mild Adverse Event <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-nciThesaurus.html">NCI Thesaurus</a>#C41338)</span></p><blockquote><p><b>Participant</b></p><blockquote><p><b>url</b></p><code>function</code></blockquote><p><b>value</b>: authenticator <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-ParticipationType.html">ParticipationType</a>#AUTHEN)</span></p><blockquote><p><b>url</b></p><code>actor</code></blockquote><p><b>value</b>: <a href="Practitioner-practitioner-owen-oncologist.html">Practitioner/practitioner-owen-oncologist</a> " ONCOLOGIST"</p></blockquote><blockquote><p><b>Suspect Entity</b></p><blockquote><p><b>url</b></p><code>instance</code></blockquote><p><b>value</b>: <a href="MedicationAdministration-medication-administration-kadcyla.html">MedicationAdministration/medication-administration-kadcyla</a></p><blockquote><p><b>url</b></p><code>causality</code></blockquote></blockquote><blockquote><p><b>Suspect Entity</b></p><blockquote><p><b>url</b></p><code>instance</code></blockquote><p><b>value</b>: <a href="MedicationAdministration-medication-administration-tucatinib.html">MedicationAdministration/medication-administration-tucatinib</a></p><blockquote><p><b>url</b></p><code>causality</code></blockquote></blockquote><p><b>Expected In Research Study</b>: true</p><p><b>Adverse Event resolution date</b>: 2020-06-10</p><p><b>Note</b>: treatment given with reduced dose per protocol guidelines</p><blockquote><p><b>Mitigating Action</b></p><blockquote><p><b>url</b></p><code>item</code></blockquote><p><b>value</b>: <a href="MedicationAdministration-medication-administration-kadcyla-reduced.html">MedicationAdministration/medication-administration-kadcyla-reduced</a></p></blockquote><blockquote><p><b>Mitigating Action</b></p><blockquote><p><b>url</b></p><code>item</code></blockquote><p><b>value</b>: <a href="MedicationAdministration-medication-administration-tucatinib-reduced.html">MedicationAdministration/medication-administration-tucatinib-reduced</a></p></blockquote><blockquote><p><b>modifierExtension[http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/status]</b></p></blockquote><p><b>actuality</b>: actual</p><p><b>event</b>: Alanine aminotransferase (ALT) decreased to 60 <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-mdr.html">Medical Dictionary for Regulatory Activities</a>#10001551 "Alanine aminotransferase increased")</span></p><p><b>subject</b>: <a href="Patient-patient-example-kaitlyn-b.html">Patient/patient-example-kaitlyn-b</a> " BOUNCE"</p><p><b>date</b>: 2020-05-20</p><p><b>seriousness</b>: Non-serious <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-adverse-event-seriousness.html">AdverseEventSeriousness</a>#non-serious)</span></p><p><b>outcome</b>: Recovered/Resolved <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-nciThesaurus.html">NCI Thesaurus</a>#C49498)</span></p><p><b>recorder</b>: <a href="Practitioner-practitioner-oncology-nurse-jane.html">Practitioner/practitioner-oncology-nurse-jane</a> " NURSE"</p><p><b>study</b>: <a href="ResearchStudy-clinical-trial-example-compass.html">ResearchStudy/clinical-trial-example-compass</a></p></div>
</text>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/resultingEffect">
<valueReference>
<display
value="Reference to Observation of Alanine aminotransferase (ALT) decreased to 60"/>
</valueReference>
</extension>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/supporting-info">
<extension url="item">
<valueReference>
<display
value="Supporting info would have context such as an Reference to Observation of Alanine aminotransferase (ALT) decreased to 60"/>
</valueReference>
</extension>
</extension>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/ae-grade">
<valueCodeableConcept>
<coding>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C41338"/>
</coding>
<text value="Grade 1 Mild Adverse Event"/>
</valueCodeableConcept>
</extension>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/participant">
<extension url="function">
<valueCodeableConcept>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ParticipationType"/>
<code value="AUTHEN"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="actor">
<valueReference>🔗
<reference value="Practitioner/practitioner-owen-oncologist"/>
</valueReference>
</extension>
</extension>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/suspect-entity">
<extension url="instance">
<valueReference>🔗
<reference
value="MedicationAdministration/medication-administration-kadcyla"/>
</valueReference>
</extension>
<extension url="causality">
<extension url="entityRelatedness">
<valueCodeableConcept>
<coding>
<system
value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C53258"/>
<display value="Possibly Related"/>
</coding>
</valueCodeableConcept>
</extension>
</extension>
</extension>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/suspect-entity">
<extension url="instance">
<valueReference>🔗
<reference
value="MedicationAdministration/medication-administration-tucatinib"/>
</valueReference>
</extension>
<extension url="causality">
<extension url="entityRelatedness">
<valueCodeableConcept>
<coding>
<system
value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C53258"/>
<display value="Possibly Related"/>
</coding>
</valueCodeableConcept>
</extension>
</extension>
</extension>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/expected-in-research-study">
<valueBoolean value="true"/>
</extension>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/resolve-date">
<valueDateTime value="2020-06-10"/>
</extension>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/note">
<valueAnnotation>
<text
value="treatment given with reduced dose per protocol guidelines"/>
</valueAnnotation>
</extension>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/mitigating-action">
<extension url="item">
<valueReference>🔗
<reference
value="MedicationAdministration/medication-administration-kadcyla-reduced"/>
</valueReference>
</extension>
</extension>
<extension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/mitigating-action">
<extension url="item">
<valueReference>🔗
<reference
value="MedicationAdministration/medication-administration-tucatinib-reduced"/>
</valueReference>
</extension>
</extension>
<modifierExtension
url="http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/status">
<valueCode value="completed"/>
</modifierExtension>
<actuality value="actual"/>
<event>
<coding>
<system value="https://www.meddra.org"/>
<code value="10001551"/>
<display value="Alanine aminotransferase increased"/>
</coding>
<text value="Alanine aminotransferase (ALT) decreased to 60"/>
</event>
<subject>🔗
<reference value="Patient/patient-example-kaitlyn-b"/>
</subject>
<date value="2020-05-20"/>
<seriousness>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/adverse-event-seriousness"/>
<code value="non-serious"/>
<display value="Non-serious"/>
</coding>
</seriousness>
<outcome>
<coding>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C49498"/>
<display value="Recovered/Resolved"/>
</coding>
</outcome>
<recorder>🔗
<reference value="Practitioner/practitioner-oncology-nurse-jane"/>
</recorder>
<study>🔗
<reference value="ResearchStudy/clinical-trial-example-compass"/>
</study>
</AdverseEvent>